分子瘤板对耐火固体瘤患者临床结果的影响:现实世界的研究

Yan Ling1, Xiao-Dong Jiao1, Bao-Dong Qin1

  • 1Department of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai, 200072, China.

The oncologist
|July 1, 2025
PubMed
概括

分子瘤委员会 (MTB) 推的治疗方法显著改善了耐药固体瘤患者的整体存活率 (OS) 和无进展存活率 (PFS). 匹配MTB推疗法是改善瘤结果的独立因素.